US stocks are reacting to quarterly earnings releases, with notable volatility in names such as Eaton and Shopify, where profit-taking dominates despite solid financial results.
Shopify – shares down over 6% after earnings
- Revenue: $3.17B (above $3.09B est.)
- Operating income: $382M (above $329.2M)
- MRR: $212M (in line)
- GMV: $100.74B (above $98.77B est.)
- Q2 OPEX: 35–36% of revenue
Source: xStation5
American Electric Power – shares slightly higher after earnings
- Revenue: $6.02B (above $5.75B)
- Operating EPS: $1.64 (above $1.57)
- 2026 guidance: unchanged
- FY EPS: $6.15–$6.45 (vs $6.34 consensus)
Source: xStation5
Pfizer
- EPS: $0.75 (above $0.72)
- Revenue: $14.45B (above $13.84B)
- 2026 guidance: maintained
- FY EPS: $2.80–$3.00
- FY revenue: $59.5B–$62.5B (vs $61.43B)
Source: xStation5
BioNTech
- EPS: -$1.95
- Revenue: €118.1M (below €168.4M)
- Operating loss: €677.5M (wider than €658.6M est.)
- FY revenue guidance: €2.0B–€2.3B
- Site closures: Germany, Singapore, CureVac
- Workforce reduction: ~1,860 positions
- Cost savings: up to €500M annually by 2029
- Share buyback: up to $1B
Source: xStation5
Marathon Digital – shares slightly higher after strong results
- EPS: $1.65 (above $0.74)
- EBITDA: $2.76B (above $2.29B)
- Share buyback: +$5B
Source: xStation5
Eaton
- EPS: $2.81 (above $2.75)
- Revenue: $7.45B (above $7.13B)
- Electrical Americas: $3.6B (above $3.46B)
- Aerospace: $1.18B (above $1.11B)
- Electrical Global: $1.95B (above $1.78B)
- Q2 EPS: $3.00–$3.10 (vs $3.14 est.)
- FY EPS: $13.05–$13.50
- Organic growth: 9–11% (Q2 and FY)
DuPont
- EPS: $0.55 (above $0.48)
- Revenue: $1.68B (above $1.66B)
- Q2 EPS: ~$0.59 (vs $0.58 est.)
- Q2 EBITDA: ~$430M (vs $439.3M est.)
- FY EBITDA: $1.73B–$1.76B
- FY revenue: $7.16B–$7.22B
- FY EPS: $2.35–$2.40 (raised from $2.25–$2.30)
Source: xStation5
Archer-Daniels-Midland
- Revenue: $20.49B (below $20.61B)
- EPS: $0.71 (above $0.65)
- Oilseeds processing: 9.30M tons (vs 9.31M)
- Corn processing: 4.54M tons (vs 4.61M)
Source: xStation5
Daily Summary: Market euphoria shows no signs of letting up ๐
Will OpenAI launch a legal battle against Appleโ๏ฟฝ
US OPEN: Cisco shares surge; markets open higher โฐ
Stock of the week: SAP - Europeโs Digital Infrastructure Champion
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
